https://www.selleckchem.com/pr....oducts/ulixertinib-b
Objectives To formulate practice guidelines on diagnosis and management of Kawasaki disease (KD) for Indian children. Justification KD is a systemic vasculitis that predominantly affects infants and children less than 5 years of age. Coronary artery abnormalities (CAA) develop in around 15-25% of untreated children with KD. Coronary artery involvement can lead to long-term cardiovascular implications such as development of premature coronary artery disease. Diagnosis of KD is essentially clinical based on recogniti
Like
Comment
Share
